We are live on ! Find out more
BCPEM

Bain Capital Public Equity Management Portfolio holdings

AUM $1.05B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
-$209M
Cap. Flow
-$266M
Cap. Flow %
-19.34%
Top 10 Hldgs %
54.14%
Holding
112
New
50
Increased
12
Reduced
17
Closed
30

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$37.8M
2
FTV icon
Fortive
FTV
+$30M
3
CASY icon
Casey's General Stores
CASY
+$22.3M
4
NYT icon
New York Times
NYT
+$22.2M
5
RTN
Raytheon Company
RTN
+$21.8M

Top Sells

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$73.6M
2
JCI icon
Johnson Controls International
JCI
+$72.3M
3
JACK icon
Jack in the Box
JACK
+$67.5M
4
AABA
Altaba Inc
AABA
+$55M
5
NSC icon
Norfolk Southern
NSC
+$51.6M

Sector Composition

Rank Sector Weight
1 Technology 48.12%
2 Industrials 13.16%
3 Consumer Discretionary 11.45%
4 Healthcare 10.25%
5 Financials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
51
DELISTED
Dynavax Technologies
DVAX
$4.66M 0.34%
+249,052
New +$5M
AFMD
52
DELISTED
Affimed
AFMD
$4.17M 0.3%
320,901
– –
EBSB
53
DELISTED
Meridian Bancorp, Inc.
EBSB
$4.1M 0.3%
199,021
-15,240
-7% -$301K
FSCT
54
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$3.99M 0.29%
+125,000
New +$3.35M
ESL
55
DELISTED
Esterline Technologies
ESL
$3.27M 0.24%
+43,757
New +$3.59M
FMI
56
DELISTED
Foundation Medicine, Inc.
FMI
$3.09M 0.22%
+45,350
New +$2.35M
CLLS
57
Cellectis
CLLS
$285M
$2.85M 0.21%
+97,710
New +$2.66M
SGMO
58
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.1M 0.15%
128,184
-75,607
-37% -$1.12M
MUFG icon
59
Mitsubishi UFJ Financial
MUFG
$254B
$1.62M 0.12%
+97,600
New +$665K
HLT icon
60
CALL
Hilton Worldwide
HLT
$71.5B
$1.53M 0.11%
+6,500
New +$482K
PBYI icon
61
CALL
Puma Biotechnology
PBYI
$454M
$1.45M 0.11%
+4,700
New +$526K
META icon
62
PUT
Meta Platforms (Facebook)
META
$1.51T
$1.3M 0.09%
3,273
+2,606
+391% +$461K
SCPH
63
DELISTED
scPharmaceuticals
SCPH
$1.29M 0.09%
+106,794
New +$1.51M
QQQ icon
64
PUT
Invesco QQQ Trust
QQQ
$484B
$1.25M 0.09%
5,790
-12,479
-68% -$1.9M
RIGL icon
65
Rigel Pharmaceuticals
RIGL
$750M
$1.21M 0.09%
+31,096
New +$1.18M
ARD
66
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$1.13M 0.08%
53,664
-4,104
-7% -$84.3K
ATI icon
67
PUT
ATI
ATI
$31B
$938K 0.07%
+2,500
New +$59.5K
FPRX
68
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$839K 0.06%
+38,272
New +$1.23M
XRT icon
69
CALL
State Street SPDR S&P Retail ETF
XRT
$327M
$756K 0.06%
+8,000
New +$336K
JCI icon
70
CALL
Johnson Controls International
JCI
$92.2B
$694K 0.05%
20,200
– –
CMCSA icon
71
CALL
Comcast
CMCSA
$90B
$552K 0.04%
+3,850
New +$145K
CRIS icon
72
Curis
CRIS
$7.83M
$444K 0.03%
317
-24
-7% -$56.5K
GILD icon
73
PUT
Gilead Sciences
GILD
$165B
$428K 0.03%
+2,050
New +$156K
BMY icon
74
PUT
Bristol-Myers Squibb
BMY
$132B
$410K 0.03%
+7,000
New +$438K
CLVS
75
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$375K 0.03%
+3,000
New +$210K
1 2
3
4 5

Similar funds

WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 17.19% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
TL
Tirschwell & Loewy New York $731M AUM 15.44% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 88.42% 1-Year Est. Return

Bain Capital Public Equity Management's Q4 2017 Portfolio in Review

As of Q4 2017, Bain Capital Public Equity Management held 112 positions worth $1.38B, down 13% from $1.58B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Bain Capital Public Equity Management withdrew a net $266M in Q4 2017, closing 30 positions and reducing 17 holdings. Its most notable exit was Puma Biotechnology, an estimated $73.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 38% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bain Capital Public Equity Management opened a new position in Comcast worth $40.2M.

  • Bain Capital Public Equity Management's largest Q4 2017 buy was Comcast: 1,004,967 shares worth $40.2M.
  • Bain Capital Public Equity Management added most to AutoZone in Q4 2017, an estimated $20.6M increase.
  • Bain Capital Public Equity Management's biggest Q4 2017 reduction was Johnson Controls International, cutting an estimated $72.3M.
  • Bain Capital Public Equity Management fully exited Puma Biotechnology in Q4 2017, selling an estimated $73.6M.
  • Bain Capital Public Equity Management's ten largest holdings make up 54% of its $1.38B portfolio in Q4 2017.
  • Bain Capital Public Equity Management opened 50 new positions and closed 30 in Q4 2017.
  • Bain Capital Public Equity Management's portfolio value fell 13% quarter-over-quarter to $1.38B.

Based on Bain Capital Public Equity Management's 13F filing for Q4 2017, filed 14 Feb 2018.